WO2003100008A2
(en)
|
2002-05-24 |
2003-12-04 |
Schering Corporation |
Neutralizing human anti-igfr antibody
|
JP4473257B2
(ja)
*
|
2003-04-02 |
2010-06-02 |
エフ.ホフマン−ラ ロシュ アーゲー |
インスリン様成長因子i受容体に対する抗体及びその使用
|
WO2005016970A2
(en)
*
|
2003-05-01 |
2005-02-24 |
Imclone Systems Incorporated |
Fully human antibodies directed against the human insulin-like growth factor-1 receptor
|
KR100825156B1
(ko)
|
2003-08-13 |
2008-04-24 |
화이자 프로덕츠 인코포레이티드 |
변형된 인간 igf-ir 항체
|
EP1694850B1
(de)
|
2003-11-12 |
2011-06-29 |
Schering Corporation |
Plasmidsystem zur expression mehrerer gene
|
TW200526684A
(en)
*
|
2003-11-21 |
2005-08-16 |
Schering Corp |
Anti-IGFR1 antibody therapeutic combinations
|
JP5848861B2
(ja)
*
|
2004-04-20 |
2016-01-27 |
ジェンマブ エー/エスGenmab A/S |
Cd20に対するヒトモノクローナル抗体
|
CA2573821A1
(en)
|
2004-07-16 |
2006-01-26 |
Pfizer Products Inc. |
Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody
|
FR2873699B1
(fr)
*
|
2004-07-29 |
2009-08-21 |
Pierre Fabre Medicament Sa |
Nouveaux anticorps anti igf ir rt leurs utilisations
|
WO2006060419A2
(en)
|
2004-12-03 |
2006-06-08 |
Schering Corporation |
Biomarkers for pre-selection of patients for anti-igf1r therapy
|
MY146381A
(en)
|
2004-12-22 |
2012-08-15 |
Amgen Inc |
Compositions and methods relating relating to anti-igf-1 receptor antibodies
|
GB0501741D0
(en)
*
|
2005-01-27 |
2005-03-02 |
Binding Site The Ltd |
Antibody
|
CA2604393A1
(en)
*
|
2005-04-15 |
2006-10-26 |
Schering Corporation |
Methods and compositions for treating or preventing cancer
|
WO2006138315A2
(en)
*
|
2005-06-15 |
2006-12-28 |
Schering Corporation |
Anti-igf1r antibody formulations
|
CN101613409B
(zh)
*
|
2005-06-17 |
2014-06-04 |
英克隆有限责任公司 |
抗-PDGFRα抗体
|
FR2888850B1
(fr)
|
2005-07-22 |
2013-01-11 |
Pf Medicament |
Nouveaux anticorps anti-igf-ir et leurs applications
|
EP1981969A4
(de)
*
|
2006-01-19 |
2009-06-03 |
Genzyme Corp |
Gitr-antikörper für die krebsbehandlung
|
CA2641310C
(en)
|
2006-02-03 |
2013-08-20 |
Imclone Systems Incorporated |
Igf-ir antagonists as adjuvants for treatment of prostate cancer
|
MX2008010920A
(es)
|
2006-03-09 |
2008-09-03 |
Hoffmann La Roche |
Prueba de anticuerpo anti-farmaco.
|
KR20080113268A
(ko)
*
|
2006-03-28 |
2008-12-29 |
바이오겐 아이덱 엠에이 인코포레이티드 |
항 igf-1r 항체 및 그의 용도
|
KR20080104160A
(ko)
*
|
2006-03-28 |
2008-12-01 |
에프. 호프만-라 로슈 아게 |
항-igf-1r 인간 단일클론 항체 제형
|
US20080014203A1
(en)
*
|
2006-04-11 |
2008-01-17 |
Silke Hansen |
Antibodies against insulin-like growth factor I receptor and uses thereof
|
US7846724B2
(en)
|
2006-04-11 |
2010-12-07 |
Hoffmann-La Roche Inc. |
Method for selecting CHO cell for production of glycosylated antibodies
|
EP2032989B2
(de)
|
2006-06-30 |
2015-10-28 |
Merck Sharp & Dohme Corp. |
Igfbp2-biomarker
|
WO2008031532A1
(en)
|
2006-09-12 |
2008-03-20 |
F. Hoffmann-La Roche Ag |
Anti-drug antibody assay
|
MX2009006466A
(es)
|
2006-12-13 |
2009-06-26 |
Schering Corp |
Metodos de tratamiento de cancer con inhibidores del receptor del factor 1 de crecimiento similar a la insulina.
|
WO2008098115A2
(en)
*
|
2007-02-07 |
2008-08-14 |
Xencor, Inc. |
Optimized igf-1r antibodies and methods of using the same
|
GB0702888D0
(en)
*
|
2007-02-14 |
2007-03-28 |
Glaxo Group Ltd |
Novel Antibodies
|
EP2126565B1
(de)
|
2007-02-27 |
2011-10-26 |
F. Hoffmann-La Roche AG |
Verfahren zur beurteilung der hemmungsaktivität von antikörpern gegen insulinartigen wachstumsfaktor-1-rezeptor
|
WO2008108986A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Amgen Inc. |
Methods and compositions for treating tumor diseases
|
WO2008144345A2
(en)
|
2007-05-17 |
2008-11-27 |
Bristol-Myers Squibb Company |
Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulators
|
AU2008293425B2
(en)
*
|
2007-08-31 |
2014-09-18 |
Amgen Inc. |
Solid-state protein formulation
|
EP2205280B1
(de)
|
2007-09-27 |
2019-09-04 |
Amgen Inc. |
Pharmazeutische formulierungen
|
WO2009064838A1
(en)
|
2007-11-15 |
2009-05-22 |
Amgen, Inc. |
Aqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration
|
SI2573568T1
(sl)
|
2007-12-15 |
2015-05-29 |
F. Hoffmann-La Roche Ag |
Razlikovalni test
|
EP2247757A2
(de)
*
|
2007-12-18 |
2010-11-10 |
Schering Corporation |
Biomarker für die empfindlichkeit gegenüber einer anti-igf1r-therapie
|
EP2225273B1
(de)
|
2007-12-21 |
2012-05-23 |
Roche Glycart AG |
Stabilitätsprüfung von antikörpern
|
CN102481361B
(zh)
|
2009-04-16 |
2014-10-22 |
默沙东公司 |
用于治疗癌症的组合物和方法
|
US20100316639A1
(en)
|
2009-06-16 |
2010-12-16 |
Genentech, Inc. |
Biomarkers for igf-1r inhibitor therapy
|
KR20120031083A
(ko)
|
2009-07-24 |
2012-03-29 |
에프. 호프만-라 로슈 아게 |
교반기 시스템
|
CA2776576C
(en)
|
2009-10-19 |
2018-01-02 |
F. Hoffmann-La Roche Ag |
Non-cross-reactive anti-igg antibodies
|
US9662271B2
(en)
|
2009-10-23 |
2017-05-30 |
Amgen Inc. |
Vial adapter and system
|
KR101436219B1
(ko)
|
2009-10-26 |
2014-09-01 |
에프. 호프만-라 로슈 아게 |
글리코실화된 면역글로불린의 제조 방법
|
EP2494070A2
(de)
|
2009-10-30 |
2012-09-05 |
Bristol-Myers Squibb Company |
Verfahren zur krebsbehandlung bei patienten mit igf-1r-hemmer-resistenz
|
WO2011083391A2
(en)
|
2010-01-05 |
2011-07-14 |
Pfizer Inc. |
Biomarkers for anti-igf-ir cancer therapy
|
TW201138821A
(en)
|
2010-03-26 |
2011-11-16 |
Roche Glycart Ag |
Bispecific antibodies
|
WO2011135040A1
(en)
|
2010-04-30 |
2011-11-03 |
F. Hoffmann-La Roche Ag |
Fluorescent antibody fusion protein, its production and use
|
EA032537B1
(ru)
|
2010-06-07 |
2019-06-28 |
Эмджен Инк. |
Способ работы устройства для доставки лекарственного средства
|
WO2011161119A1
(en)
|
2010-06-22 |
2011-12-29 |
F. Hoffmann-La Roche Ag |
Antibodies against insulin-like growth factor i receptor and uses thereof
|
WO2012022682A1
(en)
|
2010-08-17 |
2012-02-23 |
F. Hoffmann-La Roche Ag |
Anti-human igg1 antibody
|
JP5947802B2
(ja)
|
2010-11-05 |
2016-07-06 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
ミックスモードクロマトグラフィーによる抗体捕捉の最適化方法
|
JP2014510265A
(ja)
|
2011-02-02 |
2014-04-24 |
アムジェン インコーポレイテッド |
Igf−1rの阻害に関する方法および組成物
|
WO2012135315A1
(en)
|
2011-03-31 |
2012-10-04 |
Amgen Inc. |
Vial adapter and system
|
LT2699293T
(lt)
|
2011-04-20 |
2019-04-25 |
Amgen Inc. |
Automatinio purškimo prietaisas
|
SG195077A1
(en)
|
2011-06-22 |
2013-12-30 |
Hoffmann La Roche |
Removal of target cells by circulating virus-specific cytotoxic t-cells using mhc class i comprising complexes
|
US20140309229A1
(en)
|
2011-10-13 |
2014-10-16 |
Bristol-Myers Squibb Company |
Methods for selecting and treating cancer in patients with igf-1r/ir inhibitors
|
EP3335747B1
(de)
|
2011-10-14 |
2021-04-07 |
Amgen Inc. |
Injektor und verfahren zur montage
|
EP2776042B1
(de)
|
2011-11-11 |
2019-03-20 |
Duke University |
Wirkstoffkombinationstherapie zur behandlung von soliden tumoren
|
US8980259B2
(en)
|
2012-07-20 |
2015-03-17 |
Novartis Ag |
Combination therapy
|
EP2914629A1
(de)
|
2012-11-05 |
2015-09-09 |
MAB Discovery GmbH |
Verfahren zur herstellung multispezifischer antikörper
|
EP2727941A1
(de)
|
2012-11-05 |
2014-05-07 |
MAB Discovery GmbH |
Verfahren zur Herstellung multispezifischer Antikörper
|
ES2780395T3
(es)
|
2012-11-21 |
2020-08-25 |
Amgen Inc |
Dispositivo de administración de fármacos
|
JP6475167B2
(ja)
|
2012-12-21 |
2019-02-27 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
ジスルフィド結合した多価mhcクラスiを含む多機能タンパク質
|
US10492990B2
(en)
|
2013-03-15 |
2019-12-03 |
Amgen Inc. |
Drug cassette, autoinjector, and autoinjector system
|
WO2014152361A1
(en)
|
2013-03-15 |
2014-09-25 |
Wake Forest University Health Sciences |
Antibodies against human and canine il-13ra2
|
CN113559363B
(zh)
|
2013-03-22 |
2023-10-31 |
美国安进公司 |
注射器及装配方法
|
WO2015000865A1
(en)
|
2013-07-04 |
2015-01-08 |
F. Hoffmann-La Roche Ag |
Interference-suppressed immunoassay to detect anti-drug antibodies in serum samples
|
JP7051293B2
(ja)
|
2013-10-24 |
2022-04-11 |
アムジエン・インコーポレーテツド |
温度感知制御を伴う薬剤送達システム
|
US11097055B2
(en)
|
2013-10-24 |
2021-08-24 |
Amgen Inc. |
Injector and method of assembly
|
WO2015119906A1
(en)
|
2014-02-05 |
2015-08-13 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
SG11201609219QA
(en)
|
2014-05-07 |
2016-12-29 |
Amgen Inc |
Autoinjector with shock reducing elements
|
KR102506249B1
(ko)
|
2014-06-03 |
2023-03-03 |
암겐 인코포레이티드 |
약물 전달 시스템 및 사용 방법
|
WO2016033509A1
(en)
*
|
2014-08-29 |
2016-03-03 |
The Regents Of The University Of Colorado, A Body Corporate |
Aquaporin-4 antibodies and uses thereof for the treatment of neuromyelitis optica
|
CA2957960C
(en)
|
2014-10-14 |
2023-08-22 |
Amgen, Inc. |
Drug injection device with visual and audible indicators
|
EP3233159B1
(de)
|
2014-12-19 |
2020-03-04 |
Amgen Inc. |
Medikamentenabgabevorrichtung mit beweglicher taste oder bedienfeld
|
JP6716566B2
(ja)
|
2014-12-19 |
2020-07-01 |
アムジエン・インコーポレーテツド |
近接センサ付き薬物送達装置
|
ES2748750T3
(es)
|
2015-02-17 |
2020-03-17 |
Amgen Inc |
Dispositivo de administración de fármacos con sujeción asistida por vacío y/o realimentación
|
ES2905870T3
(es)
|
2015-02-27 |
2022-04-12 |
Amgen Inc |
Dispositivo de suministro de fármacos que tiene un mecanismo de protección de aguja con un umbral de resistencia ajustable al movimiento de la protección de aguja
|
CA2929542A1
(en)
*
|
2015-05-13 |
2016-11-13 |
Pfizer Inc. |
Treatment with anti-efna4 antibody-drug conjugates
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
US11351308B2
(en)
|
2015-12-09 |
2022-06-07 |
Amgen Inc. |
Auto-injector with signaling cap
|
US11154661B2
(en)
|
2016-01-06 |
2021-10-26 |
Amgen Inc. |
Auto-injector with signaling electronics
|
EP3721922B1
(de)
|
2016-03-15 |
2022-05-04 |
Amgen Inc. |
Verringerung der wahrscheinlichkeit auf glasbruch in arzneimittelabgabevorrichtungen
|
WO2017189089A1
(en)
|
2016-04-29 |
2017-11-02 |
Amgen Inc. |
Drug delivery device with messaging label
|
WO2017192287A1
(en)
|
2016-05-02 |
2017-11-09 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
AU2017263558B2
(en)
|
2016-05-13 |
2022-12-22 |
Amgen Inc. |
Vial sleeve assembly
|
US11238150B2
(en)
|
2016-05-16 |
2022-02-01 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
US11541176B2
(en)
|
2016-06-03 |
2023-01-03 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
WO2018004842A1
(en)
|
2016-07-01 |
2018-01-04 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
US20190328965A1
(en)
|
2016-08-17 |
2019-10-31 |
Amgen Inc. |
Drug delivery device with placement detection
|
US20200261643A1
(en)
|
2016-10-25 |
2020-08-20 |
Amgen Inc. |
On-body injector
|
AU2018210301A1
(en)
|
2017-01-17 |
2019-08-01 |
Amgen Inc. |
Injection devices and related methods of use and assembly
|
JP7064501B2
(ja)
|
2017-02-17 |
2022-05-10 |
アムジエン・インコーポレーテツド |
無菌流体流路を備える薬物送達デバイスおよび関連する組立方法
|
AU2018221351B2
(en)
|
2017-02-17 |
2023-02-23 |
Amgen Inc. |
Insertion mechanism for drug delivery device
|
CA3050927A1
(en)
|
2017-03-06 |
2018-09-13 |
Brian Stonecipher |
Drug delivery device with activation prevention feature
|
IL268478B2
(en)
|
2017-03-07 |
2023-10-01 |
Amgen Inc |
Inserting a needle using super pressure
|
JP2020509837A
(ja)
|
2017-03-09 |
2020-04-02 |
アムジエン・インコーポレーテツド |
薬剤送達装置のための挿入機構
|
CN110446512B
(zh)
|
2017-03-28 |
2022-03-18 |
美国安进公司 |
柱塞杆和注射器组件***以及方法
|
US11590294B2
(en)
|
2017-06-08 |
2023-02-28 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
EP3634546A1
(de)
|
2017-06-08 |
2020-04-15 |
Amgen Inc. |
Drehmomentangetriebene arzneimittelabgabevorrichtung
|
MX2019015472A
(es)
|
2017-06-22 |
2020-02-19 |
Amgen Inc |
Reduccion del impacto/choque de la activacion del mecanismo.
|
WO2018237225A1
(en)
|
2017-06-23 |
2018-12-27 |
Amgen Inc. |
ELECTRONIC DRUG DELIVERY DEVICE COMPRISING A CAP ACTIVATED BY A SWITCH ASSEMBLY
|
EP3651832B1
(de)
|
2017-07-14 |
2023-12-13 |
Amgen Inc. |
Nadeleinführ-retraktionssystem mit doppeltorsionsfedersystem
|
MA49626A
(fr)
|
2017-07-21 |
2020-05-27 |
Amgen Inc |
Élément d'étanchéité perméable aux gaz pour récipient à médicament et procédés d'assemblage
|
WO2019022950A1
(en)
|
2017-07-25 |
2019-01-31 |
Amgen Inc. |
DRUG DELIVERY DEVICE WITH CONTAINER ACCESS SYSTEM AND ASSEMBLY METHOD THEREOF
|
WO2019022951A1
(en)
|
2017-07-25 |
2019-01-31 |
Amgen Inc. |
DRUG DELIVERY DEVICE WITH GEAR MODULE AND ASSEMBLY METHOD THEREOF
|
EP3664863A2
(de)
|
2017-08-09 |
2020-06-17 |
Amgen Inc. |
Hydraulisch-pneumatisches druckkammer-arzneimittelabgabesystem
|
MA49897A
(fr)
|
2017-08-18 |
2020-06-24 |
Amgen Inc |
Injecteur sur-corps avec patch adhésif stérile
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
US20210332141A1
(en)
|
2017-08-30 |
2021-10-28 |
Amgen Inc. |
Insulin-like growth factor-1 receptor (igf-1r) binding proteins and methods of use
|
WO2019070472A1
(en)
|
2017-10-04 |
2019-04-11 |
Amgen Inc. |
FLOW ADAPTER FOR MEDICATION DELIVERY DEVICE
|
CN111132711B
(zh)
|
2017-10-06 |
2022-07-01 |
安进公司 |
带有联锁组件的药物递送装置及相关组装方法
|
EP3694578A1
(de)
|
2017-10-09 |
2020-08-19 |
Amgen Inc. |
Arzneimittelabgabevorrichtung mit antriebsanordnung sowie zugehöriges verfahren zur montage
|
WO2019090079A1
(en)
|
2017-11-03 |
2019-05-09 |
Amgen Inc. |
System and approaches for sterilizing a drug delivery device
|
WO2019089178A1
(en)
|
2017-11-06 |
2019-05-09 |
Amgen Inc. |
Drug delivery device with placement and flow sensing
|
WO2019090303A1
(en)
|
2017-11-06 |
2019-05-09 |
Amgen Inc. |
Fill-finish assemblies and related methods
|
CA3079665A1
(en)
|
2017-11-10 |
2019-05-16 |
Amgen Inc. |
Plungers for drug delivery devices
|
WO2019099324A1
(en)
|
2017-11-16 |
2019-05-23 |
Amgen Inc. |
Door latch mechanism for drug delivery device
|
MX2020005066A
(es)
|
2017-11-16 |
2020-08-20 |
Amgen Inc |
Autoinyector con deteccion de detencion y punto final.
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
US20210228815A1
(en)
|
2018-07-24 |
2021-07-29 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
WO2020023220A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with tacky skin attachment portion and related method of preparation
|
EP3826701A1
(de)
|
2018-07-24 |
2021-06-02 |
Amgen Inc. |
Ausgabevorrichtung zur verabreichung von arzneimitteln
|
CA3103682A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Delivery devices for administering drugs
|
EP3829692A1
(de)
|
2018-07-31 |
2021-06-09 |
Amgen Inc. |
Flüssigkeitsweganordnungen für wirkstofffreisetzungsvorrichtung
|
MA53724A
(fr)
|
2018-09-24 |
2021-12-29 |
Amgen Inc |
Systèmes et procédés de dosage interventionnel
|
AU2019350660A1
(en)
|
2018-09-28 |
2021-03-18 |
Amgen Inc. |
Muscle wire escapement activation assembly for a drug delivery device
|
AR116679A1
(es)
|
2018-10-02 |
2021-06-02 |
Amgen Inc |
Sistemas de inyección para la administración de fármacos con transmisión de fuerza interna
|
EP3860686A1
(de)
|
2018-10-05 |
2021-08-11 |
Amgen Inc. |
Medikamentenabgabevorrichtung mit dosisindikator
|
CA3109988A1
(en)
|
2018-10-15 |
2020-04-23 |
Amgen Inc. |
Platform assembly process for drug delivery device
|
SG11202103800RA
(en)
|
2018-10-15 |
2021-05-28 |
Amgen Inc |
Drug delivery device having damping mechanism
|
WO2020092056A1
(en)
|
2018-11-01 |
2020-05-07 |
Amgen Inc. |
Drug delivery devices with partial needle retraction
|
EP3873566A1
(de)
|
2018-11-01 |
2021-09-08 |
Amgen Inc. |
Vorrichtung zur verabreichung von medikamenten mit teilweisem rückzug des medikamentenabgabeelements
|
MA54057A
(fr)
|
2018-11-01 |
2022-02-09 |
Amgen Inc |
Dispositifs d'administration de médicament à rétraction partielle d'élément d'administration de médicament
|
US20220160972A1
(en)
|
2019-04-24 |
2022-05-26 |
Amgen Inc. |
Syringe sterilization verification assemblies and methods
|
CA3148261A1
(en)
|
2019-08-23 |
2021-03-04 |
Amgen Inc. |
Drug delivery device with configurable needle shield engagement components and related methods
|
CN113512116B
(zh)
|
2020-04-10 |
2022-09-20 |
苏州普乐康医药科技有限公司 |
一种抗igf-1r抗体及其应用
|
CN112794912B
(zh)
*
|
2021-04-14 |
2021-07-06 |
苏州普乐康医药科技有限公司 |
一种抗igf-1r抗体及其应用
|
WO2022246055A1
(en)
|
2021-05-21 |
2022-11-24 |
Amgen Inc. |
Method of optimizing a filling recipe for a drug container
|
WO2023143484A1
(zh)
*
|
2022-01-29 |
2023-08-03 |
明慧医药(杭州)有限公司 |
一种抗原结合蛋白及其用途
|